Conversely, transient inhibition of RANKL in murine models indicate its effect on thymic negative selection of self-reactive T cells specific for tumor antigens, and resulting in an improvement of antitumor immune response (107, 108). The gene discussed is TNFSF11; the disease is neoplasm.